Skip to main content
OpenTrials
Completed

NCT Number: NCT06380582

Indoor Air Quality, Temperature and Cognitive Performance

Study design: A cross-over single-blinded treatment design will be used. Participants will undergo 4 different conditions: (1) low air flow and 23°C, (2) low air flow and 35°C, (3) high air flow and 23°C, and (4) high air flow and 35°C. Participants will be blinded to the air quality level; however, it is not possible to blind them to the temperature condition, as they will be able to perceive it as different.

Study population: The population consists of healthy young and middle-aged adults of both sexes between 18 and 40 years.

Intervention (if applicable): Each participant undergoes 4 conditions in randomized order. Two conditions consist of poor air quality defined as 3,000 ppm carbon dioxide and 23°C or 35°C temperature, respectively.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–40 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Maastricht University

Maastricht, Limburg, 6229ER, Netherlands

About this study

Objective: This study aims to examine the effect of indoor air quality and temperature on human cognitive performance. The main research objective of this study is to examine how indoor air quality and temperature affects cognitive performance, respectively. As a secondary objective, it will be examined if a higher temperature of 35°C compared to 23°C amplifies the negative effect of low air flow vs. high air flow on cognitive performance. It will also be examined if human perceive the air quality as less pleasant under the higher temperature, even if the air quality itself does not change in terms of carbon dioxide concentration. Also, the physiological reaction towards poor air quality and elevated temperature will be examined in isolation and interaction.

Main study parameters/endpoints: The main study parameters are the achieved scores of the cognition test, mainly derived from the Cambridge Neuropsychological Test Automated Battery (CANTAB) and the Cognitive Ability Task. As secondary outcome, the physiological response will be examined. Specifically, it will be investigated how the air quality and temperature affect the following physiological parameters: Capillary blood CO2 and pH level, salivary cortisol and a-amylase and serum cytokine response, lung function, heart rate, respiration rate, skin temperature, core temperature, blood pressure, physical activity, and metabolic rate.

Primary Objective: The main research objective of this study is to examine how poor indoor air quality in terms of low air flow compared to high air flow and elevated temperature of 35°C compared to 23°C affect cognitive performance, respectively.

Secondary Objective(s): The following secondary objectives will be investigated in this study:

  • It will be examined whether the decline in cognitive performance is greater when low air quality to high air quality compared to when temperature levels are increasing from 23°C to 35°C.
  • It will be examined whether a higher temperature of 35°C compared to 23°C amplifies the negative effect of poor air quality.
  • It will be examined whether participants perceive the air quality as less satisfactory if temperature levels are higher indoors, even when the air quality is unchanged. It will be also examined to which physiological reactions poor air quality and elevated temperature lead. Specifically, the following objectives will be investigated:
  • It will be examined whether metabolic rate is affected under poor air quality conditions or higher temperature indicated by a change in CO2 production and oxygen consumption.
  • It will be examined whether poor air quality or higher temperature levels are associated with a stress response defined by a higher heart rate, higher respiration rate, higher blood pressure, higher alpha-amylase and cortisol levels, and a higher rate of non-exercise activity thermogenesis through increased physical activity.
  • It will be examined whether lung function in terms of forced expiratory volume and forced vital capacity are reduced when participants are exposed to poor air quality in combination with a higher temperature of 35°C.
  • It will be examined whether blood capillary carbon dioxide concentration and blood pH level are elevated under worse air quality in combination with a higher temperature of 35°C.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults between 18 to 40 years old
  • Western-European background
  • Generally healthy
  • No medication which may influence the outcome parameters. This will be determined on a case-by-case basis. Contraceptive uses for women are allowed and will be verified through a questionnaire.
  • Non-smokers or persons who quit smoking more than five years ago

Exclusion criteria

Participants, who do not want to be informed about unexpected medical findings, or do not wish that their treating physician will be informed, cannot participate in this study

  • Individuals with a diagnosed physical or mental disability or attention deficit hyperactivity disorder (ADHD) or depression
  • Any medication or medical condition that might interfere with the physiological outcome parameters or in some regards impair cognition
  • Unstable body weight (weight gain or loss >3kg in the past three months)
  • Participation in another biomedical study within 1 month prior to screening visit
  • Shift workers
  • Colour blindness
  • Pregnancy
  • People with a low haemoglobin or haematocrit concentration
  • Not having visited or resided in a warm country in the last 3 months
  • Participants with asthma or restricted lung function due to allergies

Treatment and study plan

Temperature and Airflow combination

Other

23C 40%Relative Humidity (RH) low airflow, 23C 40%RH high airflow, 35C 40%RH low airflow, 35C 40% high airflow

Primary outcomes

  1. Cognition Morning

    Time frame: 1 month

    Cambridge Neuropsychological Test Automated Battery (CANTAB) once at 11am and once at 230pm

  2. Cognition Afternoon

    Time frame: 1 month

    Cognitive Ability Task - once at 4pm

Secondary outcomes

  1. Heart Rate (bpm)

    Time frame: 1 month

    Using a wearable heart rate belt for beat by beat

  2. Metabolic Rate (ml/kg/min)

    Time frame: 1 month

    Omnical system with a minute frequency

  3. Blood Pressure (mmHg)

    Time frame: 1 month

    Using an automate blood pressure cuff every hour

  4. Blood samples

    Time frame: 1 month

    Blood drawn for future analysis 4 times every 2 hours

  5. Saliva samples

    Time frame: 1 month

    Saliva collected for future analysis 4 times every 2 hours

  6. Breathing rate

    Time frame: 1 month

    Spirometer used 4 times every 2 hours

Other outcomes

  1. Temperature (C)

    Time frame: 1 month

    Room temperature using an environmental sensor

  2. Humidity %

    Time frame: 1 month

    Relative Humidity using an environmental sensor

  3. Carbon dioxide (CO2) concentration (ppm)

    Time frame: 1 month

    Carbon dioxide using an environmental sensor

Sponsors and collaborators

Lead sponsor

Maastricht University Medical Center

Other

Registry information

Acronym: AEOLUS

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Apr 24, 2024
Registry last updated
Mar 24, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.